Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Motor unit number estimation.

Jeremy M Shefner1, Clifton L Gooch

  • 1Clinical Neurophysiology Laboratory, MDA/ALS Research and Treatment Center, Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA. shefnerj@upstate.edu

Physical Medicine and Rehabilitation Clinics of North America
|June 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Durable Medical Equipment in COURAGE-ALS, a Phase 3, Multicentre, Randomized Clinical Trial for ALS.

Muscle & nerve·2026
Same author

Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2025
Same author

Participant, site personnel and sponsor perspectives on decentralized trial features in COURAGE-ALS: a randomized clinical trial.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2025
Same author

Hospitalizations as an outcome measure in COURAGE-ALS.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2025
Same author

Application of the ENCALS predictive survival model in assessing the effect of the 24/44 inclusion criteria in FORTITUDE-ALS.

Journal of neuromuscular diseases·2025
Same author

Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial.

JAMA neurology·2025
Same journal

Dual Frontiers Cancer and Palliative Care.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Pain Management Across Special Populations: Pediatrics, Geriatrics, and Pregnancy.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Healing from Within: Regenerative Medicine in Pain Therapy.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

The Brain in Pain: Exploring Central Pain Disorders.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Short Circuit: Understanding and Treating Neuropathic Pain.

Physical medicine and rehabilitation clinics of North America·2026
Same journal

Breaking the Cycle: Comprehensive Strategies for Chronic Pain.

Physical medicine and rehabilitation clinics of North America·2026
See all related articles

Motor Unit Number Estimation (MUNE) techniques are valuable tools for studying neuromuscular disorders like ALS. Despite technical variability, MUNE provides unique insights into disease pathophysiology and aids therapeutic trials.

Area of Science:

  • Neurology
  • Neurophysiology

Background:

  • Motor Unit Number Estimation (MUNE) techniques have evolved over 30 years for diagnosing neuromuscular disorders.
  • Current widespread methods include statistical and Multiple Point Stimulation (MPS) MUNE, though optimal techniques are debated.

Purpose of the Study:

  • To review the advancements, applications, and ongoing challenges in MUNE techniques for neuromuscular disease research.
  • To highlight MUNE's utility in understanding disease mechanisms and its role in clinical trials.

Main Methods:

  • Review of existing literature on MUNE techniques and their applications.
  • Analysis of MUNE's performance in normal subjects and patients with neurogenic conditions.
  • Examination of MUNE's specific utility in amyotrophic lateral sclerosis (ALS) and motor neuron disease models.

Related Experiment Videos

Main Results:

  • MUNE techniques show good agreement across different methods in normal subjects and neurogenic disorders.
  • MUNE has been particularly successful in studying amyotrophic lateral sclerosis (ALS) and motor neuron disease models.
  • Ongoing research addresses standardization and reproducibility issues for MUNE methods.

Conclusions:

  • MUNE techniques offer a promising, non-invasive method for collecting novel data in living patients with neuromuscular diseases.
  • Despite methodological challenges, MUNE provides significant insights into neuromuscular disease pathophysiology.
  • MUNE is increasingly integrated into clinical therapeutic trials for neuromuscular disorders.